October 2, 2024
[10/02/2024] The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved. Tirzepatide injection has […]
October 2, 2024
As healthcare systems across Europe deal with an increasing prevalence of cognitive impairment, family doctors are emerging as key players in assessing and supporting patients’ decision-making […]
October 2, 2024
Adding supplemental external beam radiotherapy (EBRT) did not improve outcomes in higher-risk cancer patients who had brachytherapy, according to the long-term results of two trials. Specifically, […]
October 2, 2024
TOPLINE: A 0.4 mg dose of aflibercept in infancy to treat retinopathy of prematurity (ROP) shows sustained efficacy and safety at 3 years of age, according […]
October 2, 2024
Delivery Method: VIA UPS Product: DrugsFood & Beverages Recipient: Recipient Name Ryuji Hirooka Recipient Title President and Director World Nutrition, Inc. 9449 N 90th Street Ste […]
October 2, 2024
Hypofractionated (HF) whole-breast irradiation with simultaneous integrated boost (SIB) can be considered a standard of care for adjuvant radiotherapy after breast conserving surgery, new data suggests. […]
October 2, 2024
Only 1 in 15 urine dipstick tests showing proteinuria in the primary care setting are followed up with albuminuria quantification testing, according to investigators. These findings […]
October 2, 2024
PHILADELPHIA — Continuous intracerebroventricular administration of an anaerobic dopamine formulation (A-dopamine) appears safe in patients with Parkinson’s disease (PD) and may avoid complications associated with levodopa, […]
October 2, 2024
Gabrielle Jospa, 15, was diagnosed with long COVID after a serious bout with acute COVID-19 that left her hospitalized in 2021. Since then, the Long Island, […]